Bone marrow-sparing radiotherapy is an emerging approach in the treatment of cervical cancer, particularly for patients undergoing concurrent chemoradiotherapy. This technique aims to minimize ...

Instead, the radiation exposure for each patient and each scan must be ... In addition, it must be borne in mind that DXA will not be sensitive to the small changes in bone density typically seen over ...

» What is the typical staff dose from a DXA examination? The dose to staff in DXA facilities is generally small. However, new developments in DXA imaging technology (fan beam, cone beam, C-arm ...

Penn researchers have developed a platform that emulates human bone marrow’s native environment. This breakthrough addresses ...

There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Delineating the bone marrow (BM) for sparing based on computer tomography (CT) images before radiotherapy can effectively avoid this risk. Unfortunately, compared to magnetic resonance (MR ...

Results have shown that Iomab-B delivers high amounts of radiation to the primary target of the bone marrow with minimal impact on other organs, resulting in lower rates and severity of adverse ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to ...